{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:06:00Z","timestamp":1792724760255,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["Proteomics\/2020\/7280"],"award-info":[{"award-number":["Proteomics\/2020\/7280"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.arcmed.2024.102966","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T20:39:30Z","timestamp":1707338370000},"page":"102966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Human Intestinal Defensin 5 Ameliorates the Sensitization of Colonic Cancer Cells to 5-Fluorouracil"],"prefix":"10.1016","volume":"55","author":[{"given":"Anshul","family":"Panjeta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khushpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinkle","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indu","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0563-0277","authenticated-orcid":false,"given":"Simran","family":"Preet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2024.102966_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101174","article-title":"Global colorectal cancer burden in 2020 and projections to 2040","volume":"14","author":"Xi","year":"2021","journal-title":"Transl Oncol"},{"key":"10.1016\/j.arcmed.2024.102966_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173819","article-title":"Current advancements and future perspectives of immunotherapy in colorectal cancer research","volume":"893","author":"Kishore","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.arcmed.2024.102966_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107447","article-title":"5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future","volume":"206","author":"Vodenkova","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.arcmed.2024.102966_bib0004","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3892\/or.2023.8612","article-title":"5Fluorouracil and capecitabine therapies for the treatment of colorectal cancer (Review)","volume":"50","author":"Alzahrani","year":"2023","journal-title":"Oncol rep"},{"key":"10.1016\/j.arcmed.2024.102966_bib0005","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1002\/cmdc.202100473","article-title":"Mutual Prodrugs of 5-Fluorouracil: From a Classic Chemotherapeutic Agent to Novel Potential Anticancer Drugs","volume":"16","author":"Ciaffaglione","year":"2021","journal-title":"Chem Med Chem"},{"key":"10.1016\/j.arcmed.2024.102966_bib0006","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.3390\/molecules25112614","article-title":"Drug-Drug Interactions of Irinotecan, 5-Fluorouracil, Folinic Acid and Oxaliplatin and Its Activity in Colorectal Carcinoma Treatment","volume":"25","author":"Zoetemelk","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.arcmed.2024.102966_bib0007","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1111\/cas.14532","article-title":"5-Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes","volume":"111","author":"Blondy","year":"2020","journal-title":"Cancer Sci"},{"key":"10.1016\/j.arcmed.2024.102966_bib0008","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.3390\/molecules13081551","article-title":"5-Fluorouracil: mechanisms of resistance and reversal strategies","volume":"13","author":"Zhang","year":"2008","journal-title":"Molecules"},{"key":"10.1016\/j.arcmed.2024.102966_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111285","article-title":"5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition","volume":"137","author":"Sethy","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.arcmed.2024.102966_bib0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1567201043480036","article-title":"The role of ABC transporters in drug resistance, metabolism, and toxicity","volume":"1","author":"Glavinas","year":"2004","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.arcmed.2024.102966_bib0011","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2174\/138161282005140214165212","article-title":"ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development","volume":"20","author":"Choi","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.arcmed.2024.102966_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.648407","article-title":"Clinically-Relevant ABC Transporter for Anti-Cancer Drug Resistance","volume":"12","author":"Xiao","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.arcmed.2024.102966_bib0013","doi-asserted-by":"crossref","unstructured":"Karthika C, Sureshkumar R, Zehravi M, et al. Multidrug Resistance of Cancer Cells and the Vital Role of P-Glycoprotein Life 2022;12:897. 10.3390\/life12060897.","DOI":"10.3390\/life12060897"},{"key":"10.1016\/j.arcmed.2024.102966_bib0014","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.3389\/fmicb.2020.582779","article-title":"Antimicrobial peptides: classification, design, application and research progress in multiple fields","volume":"11","author":"Huan","year":"2020","journal-title":"Frontiers in microbiology"},{"key":"10.1016\/j.arcmed.2024.102966_bib0015","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.3390\/ijms21186964","article-title":"Antimicrobial Peptides as New Combination Agents in Cancer Therapeutics: A Promising Protocol against HT-29 Tumoral Spheroids","volume":"21","author":"Raileanu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.arcmed.2024.102966_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119650","article-title":"Combination therapy using Smac peptide and doxorubicin-encapsulated MUC 1-targeted polymeric nanoparticles to sensitize cancer cells to chemotherapy: An in vitro and in vivo study","volume":"587","author":"Nejabat","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.arcmed.2024.102966_bib0017","doi-asserted-by":"crossref","first-page":"801","DOI":"10.18388\/abp.2006_3309","article-title":"Antitumor effect of RGD-4C-GG-D(KLAKLAK)2 peptide in mouse B16(F10) melanoma model","volume":"53","author":"Smolarczyk","year":"2006","journal-title":"Acta Biochim Pol"},{"key":"10.1016\/j.arcmed.2024.102966_bib0018","doi-asserted-by":"crossref","first-page":"9381","DOI":"10.1073\/pnas.0403317101","article-title":"Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells","volume":"101","author":"Laakkonen","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2024.102966_bib0019","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.bbrc.2019.10.058","article-title":"Augmented therapeutic efficacy of 5-fluorouracil in conjunction with lantibiotic nisin against skin cancer","volume":"520","author":"Rana","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.arcmed.2024.102966_bib0020","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/02652048.2022.2149871","article-title":"Organogel mediated co-delivery of nisin and 5-fluorouracil: a synergistic approach against skin cancer","volume":"39","author":"Kaur","year":"2022","journal-title":"J Microencapsul"},{"key":"10.1016\/j.arcmed.2024.102966_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2020.170263","article-title":"Anticancer potential of human intestinal defensin 5 against 1, 2-dimethylhydrazine dihydrochloride induced colon cancer: A therapeutic approach","volume":"126","author":"Panjeta","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/j.arcmed.2024.102966_bib0022","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/toxres\/tfaa004","article-title":"Biochemical and molecular aspects of 1,2-dimethylhydrazine (DMH)-induced colon carcinogenesis: a review","volume":"9","author":"Venkatachalam","year":"2020","journal-title":"Toxicol Res (Camb)"},{"key":"10.1016\/j.arcmed.2024.102966_bib0023","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1615\/JEnvironPatholToxicolOncol.v27.i2.20","article-title":"Antioxidative effects of non-steroidal anti-inflammatory drugs during the initiation stages of experimental colon carcinogenesis in rats","volume":"27","author":"Kanwar","year":"2008","journal-title":"J. Environ. Pathol Toxicol Oncol"},{"key":"10.1016\/j.arcmed.2024.102966_bib0024","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.canlet.2006.11.009","article-title":"Epidemiology of colonic aberrant crypt foci: review and analysis of existing studies","volume":"252","author":"Stevens","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.arcmed.2024.102966_bib0025","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/jcp.39.10.1088","article-title":"Colorectal goblet cell sialomucin heterogeneity: its relation to malignant disease","volume":"39","author":"Sugihara","year":"1986","journal-title":"J. Clin. Pathol"},{"key":"10.1016\/j.arcmed.2024.102966_bib0026","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1053\/j.semdp.2018.10.002","article-title":"Histochemistry in the diagnosis of non-neoplastic gastrointestinal disorders","volume":"35","author":"Fitzgibbons","year":"2018","journal-title":"Semin. Diagn. Pathol"},{"key":"10.1016\/j.arcmed.2024.102966_bib0027","doi-asserted-by":"crossref","first-page":"G344","DOI":"10.1152\/ajpgi.00445.2003","article-title":"Adaptative increase of ornithine production and decrease of ammonia metabolism in rat colonocytes after hyperproteic diet ingestion","volume":"287","author":"Mouill\u00e9","year":"2004","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol"},{"key":"10.1016\/j.arcmed.2024.102966_bib0028","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/gut.20.6.484","article-title":"Method of preparing isolated colonic epithelial cells (colonocytes) for metabolic studies","volume":"20","author":"Roediger","year":"1979","journal-title":"Gut"},{"key":"10.1016\/j.arcmed.2024.102966_bib0029","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11010-010-0441-6","article-title":"Alterations in membrane fluidity and dynamics in experimental colon cancer and its chemoprevention by diclofenac","volume":"341","author":"Kaur","year":"2010","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.arcmed.2024.102966_bib0030","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1021\/bi00513a012","article-title":"Kinetics of soluble lipid monomer diffusion between vesicles","volume":"20","author":"Nichols","year":"1981","journal-title":"Biochemistry"},{"key":"10.1016\/j.arcmed.2024.102966_bib0031","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1021\/bi00534a036","article-title":"Fluorescence method for measuring the kinetics of Ca2+-induced phase separations in phophatidylserine-containing lipid vesicles","volume":"21","author":"Hoekstra","year":"1982","journal-title":"Biochemistry"},{"key":"10.1016\/j.arcmed.2024.102966_bib0032","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1387-2656(05)11004-7","article-title":"Tetrazolium dyes as tools in cell biology: New insights into their cellular reduction","volume":"11","author":"Berridge","year":"2005","journal-title":"Biotechnol. Annu. Rev"},{"key":"10.1016\/j.arcmed.2024.102966_bib0033","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.acthis.2018.02.005","article-title":"Tetrazolium salts and formazan products in Cell Biology: Viability assessment, fluorescence imaging, and labeling perspectives","volume":"120","author":"Stockert","year":"2018","journal-title":"Acta Histochem"},{"key":"10.1016\/j.arcmed.2024.102966_bib0034","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.arcmed.2024.102966_bib0035","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzym. Regul"},{"key":"10.1016\/j.arcmed.2024.102966_bib0036","first-page":"203e207","article-title":"Induction of cytotoxicity by selected nanoparticles in Chinese hamster ovary- K1 cells","volume":"5","author":"Vidya","year":"2017","journal-title":"Int J Biotechnol Appl"},{"key":"10.1016\/j.arcmed.2024.102966_bib0037","doi-asserted-by":"crossref","first-page":"15","DOI":"10.12659\/MSMBR.893327","article-title":"Dual AO\/EB staining to detect apoptosis in osteosarcoma cells compared with flow cytometry","volume":"21","author":"Liu","year":"2015","journal-title":"Med Sci Monit Basic Res"},{"key":"10.1016\/j.arcmed.2024.102966_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102144","article-title":"Apigenin enhances apoptosis induction by 5-fluorouracil through regulation of thymidylate synthase in colorectal cancer cells","volume":"47","author":"Yang","year":"2021","journal-title":"Redox Biol"},{"key":"10.1016\/j.arcmed.2024.102966_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.112809","article-title":"Human \u03b1-defensin 5 suppressed colon cancer growth by targeting PI3K pathway","volume":"407","author":"Qiao","year":"2021","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.arcmed.2024.102966_bib0040","first-page":"12","article-title":"Comprehensive analysis of alfa defensin expression and prognosis in human colorectal cancer","author":"Xinliang","year":"2023","journal-title":"Front in Oncol"},{"key":"10.1016\/j.arcmed.2024.102966_bib0041","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nri3607","article-title":"Apoptotic cell clearance: basic biology and therapeutic potential","volume":"14","author":"Poon","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.arcmed.2024.102966_bib0042","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0065-230X(06)98005-1","article-title":"Reversal of tumor resistance to apoptotic stimuli by alteration of membrane fluidity: therapeutic implications","volume":"98","author":"Baritaki","year":"2007","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.arcmed.2024.102966_bib0043","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1186\/s12885-017-3772-9","article-title":"Does anthracycline-based chemotherapy in pregnant women with cancer offer safe cardiac and neurodevelopmental outcomes for the developing fetus?","volume":"17","author":"Framarino-Dei-Malatesta","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.arcmed.2024.102966_bib0044","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.bpj.2009.05.066","article-title":"Arginine-rich peptides destabilize the plasma membrane, consistent with a pore formation translocation mechanism of cell-penetrating peptides","volume":"97","author":"Herce","year":"2009","journal-title":"Biophys J"},{"key":"10.1016\/j.arcmed.2024.102966_bib0045","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/s41467-022-28741-7","article-title":"Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer","volume":"13","author":"Lopez","year":"2022","journal-title":"Nature communications"},{"key":"10.1016\/j.arcmed.2024.102966_bib0046","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1038\/onc.2011.497","article-title":"Predominant requirement of Bax for apoptosis in HCT116 cells is determined by Mcl-1\u2019s inhibitory effect on Bak","volume":"31","author":"Wang","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.arcmed.2024.102966_bib0047","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.3390\/cancers12071963","article-title":"The multidrug resistance-reversing activity of a novel antimicrobial peptide","volume":"12","author":"Teng","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.arcmed.2024.102966_bib0048","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3390\/biology10090854","article-title":"Recent updates on mechanisms of resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer Treatment","volume":"10","author":"Azwar","year":"2021","journal-title":"Biology"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440924000195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440924000195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T04:28:51Z","timestamp":1777523331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440924000195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0188440924000195"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2024.102966","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human Intestinal Defensin 5 Ameliorates the Sensitization of Colonic Cancer Cells to 5-Fluorouracil","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2024.102966","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102966"}}